Bharat Parenterals Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Consistent revenue growth over the last three quarters indicates strong demand for products.
Improved gross margins reflect better cost management and pricing strategies.
Increased operational efficiency leading to higher profit margins compared to previous quarters.

NEGATIVES

Rising raw material costs are squeezing profit margins and impacting overall profitability.
High debt levels may restrict financial flexibility and increase risk in volatile markets.
A slowdown in export markets could affect future growth prospects and revenue diversification.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	69.91	59.81	59.82	67.82	92.51	71.63	72.26	103.98	116
Expenses	59.46	55.48	53.21	66.82	88.02	79.28	68.62	101.74	102.22
Operating Profit	10.45	4.33	6.61	1	4.49	-7.65	3.64	2.24	13.78
Other Income	2.10	2.59	1.26	2.64	2.54	4.20	2.95	1.92	1.06
Interest	0.89	0.63	0.58	1.13	2.77	2.91	3.33	3.94	3.69
Depreciation	1.58	1.75	1.82	3.87	9.03	9.01	8.76	8.52	8.60
Profit Before Tax	10.08	4.54	5.47	-1.36	-4.77	-15.37	-5.50	-8.30	2.55
Tax	3.07	2.11	1.83	1.20	4.07	2.15	2.37	1.14	3.42
Net Profit	7.01	2.43	3.64	-2.56	-8.84	-17.52	-7.87	-9.44	-0.87
Eps in Rs	13.03	6	6	-0.62	-14.71	-27	-10	-14.40	-1.27